https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL promotes an innovative project to store biomedical images through DNA encryption

11 de March de 2026

María Isabel Martínez Rodríguez, head of the Molecular Imaging Group at the Valdecilla Health Research Institute (IDIVAL) and a Nuclear Medicine specialist at the Marqués de Valdecilla University Hospital (HUMV), has been awarded one of the grants from the INNVAL program for her project “Storage and retrieval of biomedical images through DNA encryption and encapsulation […]

Read more →

IDIVAL reaffirms its commitment to transparency and animal welfare in research

9 de March de 2026

The Marqués de Valdecilla Research Institute (IDIVAL) reaffirms its commitment to ethical, responsible, and transparent scientific research, in line with the Transparency Agreement on the use of animals in scientific experimentation promoted by the Confederation of Scientific Societies of Spain (COSCE). The recent annual report published by this entity highlights a particularly relevant figure: in […]

Read more →

Carlos Amado, awarded in INNVAL for a pioneering project to personalize respiratory rehabilitation in COPD

5 de March de 2026

Carlos Amado, specialist in Pulmonology at the Marqués de Valdecilla University Hospital, researcher at the Valdecilla Health Research Institute (IDIVAL), and associate professor at the University of Cantabria, has been one of the professionals recognized in the latest INNVAL program call for an innovation project focused on respiratory rehabilitation in patients with chronic obstructive pulmonary […]

Read more →

A roadmap approved to transform the healthcare response to metabolic dysfunction-associated fatty liver disease

4 de March de 2026

The scientific conference “Innovation and Equity in Addressing Metabolic Dysfunction-Associated Fatty Liver Disease: A Commitment to People Living with Obesity,” held today at the headquarters of the Spanish Medical Association (OMC) on the occasion of World Obesity Day, concluded with the approval of the Madrid Declaration on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), a document […]

Read more →

Javier Crespo to take part in the Conference “Innovation and Equity in Addressing Metabolic-Associated Fatty Liver Disease”

2 de March de 2026

Javier Crespo will participate in the scientific and social conference “Innovation and Equity in Addressing Metabolic-Associated Fatty Liver Disease. A Commitment to People Living with Obesity,” to be held on March 4 at the headquarters of the Spanish Medical Association (OMC), coinciding with World Obesity Day. The meeting will bring together experts from different disciplines […]

Read more →

Fernando Rivadeneira highlights the clinical impact of polygenic risk scores at the Santander Biomedical Lectures at IDIVAL

27 de February de 2026

The Santander Biomedical Lectures program held a new session featuring Fernando Rivadeneira, Professor of Translational Genomics at Erasmus MC and an internationally recognized leader in genetics, clinical epidemiology, and musculoskeletal diseases, honored with distinctions such as the Fuller Albright Award. During his lecture, entitled “Clinical Applications of Polygenic Risk Scores,” he delivered a clear and […]

Read more →

Upcoming opening and presentation of IDIVAL’s NEXT-VAL 2026 Program

26 de February de 2026

The Marqués de Valdecilla Research Institute (IDIVAL) announces the upcoming launch of the 2026 call for proposals of the NEXT-VAL Program, an initiative aimed at promoting the development of translational research projects within the biosanitary environment of Cantabria. The program is intended for emerging principal investigators who have not previously obtained competitive funding as principal […]

Read more →

4th edition of the National Forum on Innovation Management in Health – Building Minds

25 de February de 2026

The Marqués de Valdecilla Research Institute (IDIVAL) and the Health Department of the Government of Cantabria are organizing the 4th edition of the National Forum on Innovation Management in Health – Building Minds, an event that has already become a benchmark space for the exchange of knowledge, experiences, and reflection on innovation in the healthcare […]

Read more →

Paula Iruzubieta promotes a one-step strategy to assess liver and cardiovascular risk in patients with metabolic fatty liver disease

Paula Iruzubieta, a specialist in Digestive Diseases at the Marqués de Valdecilla University Hospital and a researcher in the field of hepatology, has been selected in the INNVAL 2025 call for proposals. Her project, called ESPERANZA, proposes a new care strategy to improve risk stratification in patients with metabolic dysfunction–associated steatotic liver disease (MASLD), one […]

Read more →

Robotic surgery and intracorporeal anastomosis improve quality of life after right colon cancer surgery

23 de February de 2026

A European study led by IDIVAL confirms fewer hernias and better quality of life without affecting oncological outcomes The Surgical Innovation and Research Group of the Marqués de Valdecilla Health Research Institute (IDIVAL) has published a new article from the European MIRCAST project, the largest prospective multicenter study to date on minimally invasive right colectomy. […]

Read more →